Similar Articles
1251 Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma
1252 Mitochondrial DNA alterations and mitochondrial dysfunction in the progression of hepatocellular carcinoma
1253 Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection
1254 131I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma
1255 Added value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients
1256 Antiviral drug resistance increases hepatocellular carcinoma: A prospective decompensated cirrhosis cohort study
1257 Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation
1258 Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: Dysregulation and implications for early detection, diagnosis and therapy
1259 “Metroticket” predictor for assessing liver transplantation to treat hepatocellular carcinoma: A single-center analysis in mainland China
1260 Role of innate immunity in the development of hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA